These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9221300)

  • 1. [Drug therapy of tachycardic atrial arrhythmias].
    Wietholt D; Gülker H
    Med Klin (Munich); 1997 Apr; 92(4):197-201. PubMed ID: 9221300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute therapy of tachycardic arrhythmias. 2: Supraventricular tachycardia--atrioventricular tachycardia (WPW syndrome)].
    Gonska BD; Rab J
    Fortschr Med; 1995 Mar; 113(7):87-9. PubMed ID: 7750890
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to therapy of supraventricular tachyarrhythmias: an algorithm versus individualized therapy.
    Waldo AL
    Clin Cardiol; 1994 Sep; 17(9 Suppl 2):II21-6. PubMed ID: 7882610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Supraventricular tachycardia--practical diagnostic and therapeutic measures].
    Muders F
    MMW Fortschr Med; 2004 Jan; 146(1-2):32-3, 35. PubMed ID: 18437866
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of almokalant, a class III antiarrhythmic agent, on supraventricular, reentrant tachycardias. Almokalant Paroxysmal Supraventricular Tachycardia Study Group.
    Darpö B; Edvardsson N
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):499-508. PubMed ID: 9310280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential indications for anti-arrhythmia therapy].
    Manz M; Wagner WL; Lüderitz B
    Internist (Berl); 1987 Mar; 28(3):182-9. PubMed ID: 2438248
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems with anti-arrhythmia therapy in atrial fibrillation].
    Breithardt G; Kottkamp H; Haverkamp W; Hindricks G; Fetsch T; Borggrefe M
    Z Kardiol; 1994; 83 Suppl 5():63-9. PubMed ID: 7846947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
    Weismüller P; Kattenbeck K; Heinroth KM; Ranke C; Trappe HJ
    Dtsch Med Wochenschr; 2000 Aug; 125(33):961-9. PubMed ID: 10994404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow QRS complex tachycardias.
    Jacobson C
    AACN Adv Crit Care; 2007; 18(3):264-74. PubMed ID: 18019517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Supraventricular tachycardias: mechanism, diagnosis and therapy].
    Osswald S; Buser PT; Rickenbacher P; Pfisterer M
    Schweiz Med Wochenschr; 1996 Jun; 126(22):974-85. PubMed ID: 8693318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraventricular tachycardia in children.
    Van der Merwe DM; Van der Merwe PL
    Cardiovasc J S Afr; 2004; 15(2):64-9. PubMed ID: 15148540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M; Beermann J; Gerckens U; Lüderitz B
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping and ablation of left atrial tachycardias occurring after atrial fibrillation ablation.
    Gerstenfeld EP; Marchlinski FE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S65-72. PubMed ID: 17336888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 25 years of insights into the mechanisms of supraventricular arrhythmias.
    Wellens HJ
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1916-22. PubMed ID: 12930516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Supraventricular tachycardia in infants, children and adolescents: diagnosis, drug and interventional therapy].
    Paul T; Bertram H; Kriebel T; Windhagen-Mahnert B; Tebbenjohanns J; Hausdorf G
    Z Kardiol; 2000 Jun; 89(6):546-58. PubMed ID: 10929440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].
    Pott C; Dechering DG; Muszynski A; Zellerhoff S; Bittner A; Wasmer K; Mönnig G; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):228-38. PubMed ID: 21113605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S; Ricard P
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of supraventricular arrhythmias in adults with congenital heart disease.
    Wasmer K; Eckardt L
    Heart; 2016 Oct; 102(20):1614-9. PubMed ID: 27312002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.